Arabi Peyman, Özer Necla, Ateş Ahmet Hakan, Yorgun Hikmet, Oto Ali, Aytemir Kudret
hacettepe university.
Cardiol J. 2015;22(6):637-44. doi: 10.5603/CJ.a2015.0060. Epub 2015 Sep 28.
The aim of this study was to assess the effect of trans-tricuspid placement of permanent pacemaker (PPM), implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy (CRT) leads prospectively on tricuspid valve and right-sided heart functions using two-dimensional echocardiography.
A total of 41 patients (31 male, mean age: 63.6 ± 12.2 years) were included in this prospective study. Initial echocardiographic evaluation was performed before cardiac device implantation and re-evaluation by echocardiography was performed immediately after the procedure and at 1st, 6th and 12th months. In addition to standard echocardiographic examinations, vena contracta (VC), proximal isovelocity surface area (PISA), and tissue Doppler evaluations were also performed in the study population.
Tricuspid regurgitation (TR) is worsened by 1 grade in 70.8% of the patients and 2 grades in 17.1% of the patients in the follow-up. Eight patients without baseline TR developed new-onset TR (9.8% mild, 9.8% moderate) after lead implantation. In the follow-up period, 41.5% of the patients who had mild TR before lead implantation developed moderate TR and 7.3% developed severe TR, whereas 19.5% of the patients with moderate TR developed severe TR during the follow-up. In the follow-up period, VC of TR was increased [median: 0.32 (0.16-0.60) cm in pre-implantation period, and 0.41 (0.18-0.80) cm at 12th month, p = 0.001]. Similarly PISA value of TR was also increased [median: 0.46 (0.15-1.10) cm in pre-implantation period and 0.52 (0.28-1.20) cm at 12th month, p = 0.001]. However, there is not a significant difference between PPMs/ICDs and CRTs regarding the effects on TR (p < 0.05). In addition, right ventricular dimensions and right atrial volumes were increased during the follow-up.
Implantation of permanent transvenous right ventricular electrode is associated with worsening of TR, right atrial and right ventricular dimensions. Further studies are needed in order to both outline the effect of those findings on outcomes and clarify the time dependent changes in those functions.
本研究的目的是前瞻性地评估使用二维超声心动图,经三尖瓣植入永久性起搏器(PPM)、植入式心脏复律除颤器(ICD)和心脏再同步治疗(CRT)导线对三尖瓣和右心功能的影响。
本前瞻性研究共纳入41例患者(31例男性,平均年龄:63.6±12.2岁)。在心脏设备植入前进行初始超声心动图评估,并在术后立即以及第1、6和12个月通过超声心动图进行重新评估。除了标准的超声心动图检查外,还对研究人群进行了反流束缩流宽度(VC)、近端等速表面积(PISA)和组织多普勒评估。
在随访中,70.8%的患者三尖瓣反流(TR)加重1级,17.1%的患者加重2级。8例术前无TR的患者在导线植入后出现新发TR(9.8%为轻度,9.8%为中度)。在随访期间,术前轻度TR的患者中有41.5%进展为中度TR,7.3%进展为重度TR,而中度TR的患者中有19.5%在随访期间进展为重度TR。在随访期间,TR的VC增加[植入前中位数:0.32(0.16 - 0.60)cm,第12个月时为0.41(0.18 - 0.80)cm,p = 0.001]。同样,TR的PISA值也增加[植入前中位数:0.46(0.15 - 1.10)cm,第12个月时为0.52(0.28 - 1.20)cm,p = 0.001]。然而,PPM/ICD与CRT对TR的影响之间无显著差异(p < 0.05)。此外,随访期间右心室尺寸和右心房容积增加。
永久性经静脉右心室电极植入与TR恶化、右心房和右心室尺寸增加有关。需要进一步研究以阐明这些发现对预后的影响,并明确这些功能随时间的变化。